162 related articles for article (PubMed ID: 38577570)
1. Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China.
Le K; Jin L; Zhong F; Huang X; Zhou L; Zhou J; Xie L
Front Endocrinol (Lausanne); 2024; 15():1359621. PubMed ID: 38577570
[TBL] [Abstract][Full Text] [Related]
2. [Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma].
Liu J; Xu C; Yao X; Zhao R; Zhang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):150-156. PubMed ID: 36756834
[No Abstract] [Full Text] [Related]
3. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
4. Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.
Miyauchi A; Kudo T; Ito Y; Oda H; Yamamoto M; Sasai H; Higashiyama T; Masuoka H; Fukushima M; Kihara M; Miya A
Surgery; 2019 Jan; 165(1):25-30. PubMed ID: 30413323
[TBL] [Abstract][Full Text] [Related]
5. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
[TBL] [Abstract][Full Text] [Related]
6. Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Oh HS; Ha J; Kim HI; Kim TH; Kim WG; Lim DJ; Kim TY; Kim SW; Kim WB; Shong YK; Chung JH; Baek JH
Thyroid; 2018 Dec; 28(12):1587-1594. PubMed ID: 30226447
[TBL] [Abstract][Full Text] [Related]
7. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma.
Jeon MJ; Kim WG; Kim TY; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2021 Aug; 36(4):717-724. PubMed ID: 34379969
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid microcarcinoma: Is active surveillance always enough?
Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML
Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503
[TBL] [Abstract][Full Text] [Related]
9. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
[No Abstract] [Full Text] [Related]
10. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
11. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
Ito Y; Miyauchi A
Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
[No Abstract] [Full Text] [Related]
12. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Surgery; 2024 Apr; 175(4):1089-1094. PubMed ID: 38142143
[TBL] [Abstract][Full Text] [Related]
13. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
14. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
Jin M; Kim HI; Ha J; Jeon MJ; Kim WG; Lim DJ; Kim TY; Chung JH; Shong YK; Kim TH; Kim WB
Thyroid; 2021 Oct; 31(10):1494-1501. PubMed ID: 34225475
[No Abstract] [Full Text] [Related]
15. The occurrence of and predictive factors for multifocality and bilaterality in patients with papillary thyroid microcarcinoma.
Kaliszewski K; Diakowska D; Wojtczak B; Migoń J; Kasprzyk A; Rudnicki J
Medicine (Baltimore); 2019 May; 98(19):e15609. PubMed ID: 31083255
[TBL] [Abstract][Full Text] [Related]
16. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
17. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma.
Moon JH; Ryu CH; Cho SW; Choi JY; Chung EJ; Hah JH; Hwangbo Y; Jeong WJ; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee EK; Lee JY; Lee KE; Lee YJ; Lee Y; Yu HW; Park DJ; Ryu J; Park YJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):724-735. PubMed ID: 33248442
[TBL] [Abstract][Full Text] [Related]
18. Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.
Ito Y; Miyauchi A; Kudo T; Higashiyama T; Masuoka H; Kihara M; Miya A
Thyroid; 2019 Dec; 29(12):1765-1773. PubMed ID: 31650907
[No Abstract] [Full Text] [Related]
19. Active surveillance as a management strategy for papillary thyroid microcarcinoma.
Zhang H; Zheng X; Liu J; Gao M; Qian B
Cancer Biol Med; 2020 Aug; 17(3):543-554. PubMed ID: 32944389
[TBL] [Abstract][Full Text] [Related]
20. Observational management of papillary microcarcinoma appearing in the remnant thyroid after hemithyroidectomy.
Noda T; Miyauchi A; Ito Y; Kudo T; Sano T; Sasaki T; Ando T; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A
Endocr J; 2022 Jun; 69(6):635-641. PubMed ID: 34955475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]